282
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Intrathecal Vincristine: Fatal Myeloencephalopathy Despite Cerebrospinal Fluid Perfusion

, , &
Pages 557-561 | Published online: 08 Jan 2002

REFERENCES

  • Csuka O., Sugar J., Palgi I., Somfai-Relle S. The Mode of Action of Vinca Alkaloids. Oncology 1980; 37(Suppl. 1)83–87
  • Johnson I.S., Armstrong J.G., Gorman M., Burnett J.P. The Vinca Alkaloids: A New Class of Oncolytic Agents. Cancer Res. 1963; 23: 1390–1427
  • Rosenthal S., Kaufman S. Vincristine Neurotoxicity. Ann. Intern. Med. 1974; 80: 733–737
  • McLeod J.G., Penny R. Vincristine Neuropathy: An Electrophysiological and Histological Study. J. Neurol. Neurosurg. Psychiatr. 1969; 32: 297–304
  • Jackson D.V., Sethi V.S., Spurr C.L., McWhorter J.M. Pharmacokinetics of Vincristine in the Cerebrospinal Fluid of Humans. Cancer Res. 1981; 41: 1466–1468
  • Schochet S.S., Lampert P.W. Neuronal Changes Induced by Intrathecal Vincristine Sulfate. J. Neuropathol. Exp. Neurol. 1968; 27: 645–658
  • Shepherd D.A., Steuber C.P., Starling K.A., Fernbach D.J. Accidental Intrathecal Administration of Vincristine. Med. Pediatr. Oncol. 1978; 5: 85–88
  • Slyter H., Liwnicz B., Herrick M.K., Mason R. Fatal Myeloencephalopathy Caused by Intrathecal Vincristine. Neurology 1980; 30: 867–871
  • Manelis J., Freundlich E., Ezekiel E., Doron J. Accidental Intrathecal Vincristine Administration. J. Neurol. 1982; 228: 209–213
  • Williams M.E., Walker A.N., Bracikowski J.P., Garner L., Wilson K.D., Carpenter J.T. Ascending Myeloencephalopathy Due to Intrathecal Vincristine Sulfate. A Fatal Chemotherapeutic Error. Cancer 1983; 51: 2041–2047
  • Gaidys W.G., Dickerman J.D., Walters C.L., Young P.C. Intrathecal Vincristine. Report of a Fatal Case Despite CNS Washout. Cancer 1983; 52: 799–801
  • Dyke R.W. Treatment of Inadvertent Intrathecal Injection of Vincristine. N. Engl. J. Med. 1989; 321: 1270–1271
  • Bain P.G., Lantos P.L., Djurovic V., West I. Intrathecal Vincristine: A Fatal Chemotherapeutic Error with Devastating Central Nervous System Effects. J. Neurol. 1991; 238: 230–234
  • Bleck T.P., Jacobsen J. Prolonged Survival Following the Inadvertent Intrathecal Administration of Vincristine: Clinical and Electrophysiologic Analyses. Clin. Neuropharmacol. 1991; 14: 457–462
  • Al Fawaz I.M. Fatal Myeloencephalopathy Due to Intrathecal Vincristine Administration. Ann. Trop. Paediatr. 1992; 12: 339–342
  • Zaragoza M.R., Ritchey M.L., Walter A. Neurourologic Consequences of Accidental Intrathecal Vincristine: A Case Report. Med. Pediatr. Oncol. 1995; 24: 61–62
  • Michelagnoli M.P., Bailey C.C., Wilson I., Livingston J., Kinsey S.E. Potential Salvage Therapy for Inadvertent Intrathecal Administration of Vincristine. Br. J. Haematol. 1997; 99: 364–367
  • Meggs W.J., Hoffman R.S. Fatality Resulting from Intraventricular Vincristine Administration. J. Toxicol. Clin. Toxicol. 1998; 36: 243–246
  • Fernandez C.V., Esau R., Hamilton D., Fitzsimmons B., Pritchard S. Intrathecal Vincristine: An Analysis of Reasons for Recurrent Fatal Chemotherapeutic Error with Recommendations for Prevention. J. Pediatr. Hematol. Oncol. 1998; 20: 587–590
  • Al Ferayan A., Russell N.A., Al Wohaibi M., Awada A., Scherman B. Cerebrospinal Fluid Lavage in the Treatment of Inadvertent intrathecal Vincristine Injection. Child's Nerv. Syst. 1999; 15: 87–89
  • Kwack E.K., Kim D.J., Park T.I., Cho K.R., Kwon I.H., Sohn Y.K. Neural Toxicity Induced by Accidental Intrathecal Vincristine Administration. J. Korean Med. Sci. 1999; 14: 688–692
  • Holland J.F., Scharlan C., Galiani S. Vincristine Treatment of Advanced Cancer, a Cooperative Study of 392 Cases. Cancer Res. 1973; 33: 1258–1264
  • Rieselbach R.E., DiChiro G., Freireich E.J., Rall D.P. Subarachnoid Distribution of Drugs After Lumbar Injection. N. Engl. J. Med. 1962; 267: 1273–1278
  • Jackson D.V., Wells H.B., Atkins J.N., Zekan P.J., White D.R., Richards F., Cruz J.M., Muss H.B. Amelioration of Vincristine Neurotoxicity by Glutamic Acid. Am. J. Med. 1988; 84: 1016–1022
  • Griffin J.W., Watson D.F. Axonal Transport in Neurological Disease. Ann. Neurol. 1988; 23: 3–13
  • Solimando D.A., Wilson J.P. Prevention of Accidental Intrathecal Administration of Vincristine Sulfate. Hosp. Pharm. 1982; 17: 540–542
  • Trinkle R., Wu J.K. Errors Involving Pediatric Patients Receiving Chemotherapy: A Literature Review. Med. Pediatr. Oncol. 1996; 26: 344–351
  • Ozgen U., Soylu H., Onal S.C., Mizrak B., Turkoz Y., Kutlu N.O., Kocak A., Ozcan C., Koltuksuz U., Erten S.F., Akein U. Potential Salvage Therapy for Accidental Intrathecal Vincristine Administration: A Preliminary Experimental Study. Chemotherapy 2000; 46: 322–326
  • Berwick D.M. Not Again. Br. Med. J. 2001; 322: 247–248
  • Root T. Appropriate Training Should Avoid Accidental Intrathecal Injection of Vincristine. Br. Med. J. 2001; 322: 1423

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.